Thyroid disease

The Association Between Hypothyroidism and Cognitive Function Change in Women across the Menopause Transition: The Study of Women’s Health Across the Nation

ThyroidPublished Multisite longitudinal cohort study

Authors' conclusion

We observed no difference in cognitive decline between women with LT4-treated hypothyroidism and women without thyroid disease.

Study context

Population
Diverse midlife women across the menopause transition, 5 ethnic/racial groups, 7 US sites (Study of Women's Health Across the Nation)
Participants
2,033 women
Exposure
Levothyroxine (LT4)-treated hypothyroidism vs control women without thyroid disease
  • LT4-treated hypothyroidismn = 227
Outcome
Cognitive function trajectories (processing speed, working memory, episodic memory: immediate and delayed recall) over up to 9 assessments
Methodological detailsmultivariable generalized linear mixed models
  • Multivariable generalized linear mixed models

Main finding

As reported in the abstract

Rate of cognitive decline (any measure) · over time
  • No significant differences in rate of cognitive decline (any measure) between hypothyroidism and control groups, with or without covariate adjustment

Observational data: associations, not effects.

Further findings

Mean

OutcomeLT4-treated hypothyroidismControlP value
Processing speed score at baselineHigher with LT4-treated56.554.4P = 0.006
Working memory score at baselineHigher with LT4-treated6.86.4P = 0.018

Sensitivity analyses: abnormal thyroid stimulating hormone (TSH) levels, minimized practice effects

Results similar for LT4-treated women with abnormal TSH or after minimizing practice effects

Original publication

The Association Between Hypothyroidism and Cognitive Function Change in Women across the Menopause Transition: The Study of Women’s Health Across the Nation. Thyroid. Published 3 September 2024. doi:10.1089/thy.2024.0358

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.